Jasper Therapeutics JSPR
NASDAQ JSPR
$0.70 +0.01 (+2.02%)
At close: Sep 10, 2026 · 4:00 PM EDT

Jasper Therapeutics (JSPR) Prepaid Assets (2019 - 2026)

Jasper Therapeutics (JSPR) posted Prepaid Assets of $3.8 million for Q2 2026, down 35.49% on a QoQ basis from $6.0 million in Q4 2025, and up 11.11% year-over-year from $3.5 million in Q2 2025.

Analysis

Jasper Therapeutics (JSPR) Prepaid Assets (2019 - 2026) Analysis & Trends

Jasper Therapeutics has reported Prepaid Assets for 8 years, with the latest figure at $3.8 million in Q2 2026.

  • On a quarterly basis, Prepaid Assets rose 11.11% year-over-year to $3.8 million in Q2 2026; TTM through Jun 2026 was $3.8 million, a 11.11% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, up 42.62% from the prior year.
  • Prepaid Assets was $3.8 million for Q2 2026 at Jasper Therapeutics, down from $6.0 million in the prior quarter.
  • The five-year high for Prepaid Assets was $6.0 million in Q4 2025, with the low at $1.4 million in Q3 2023.
  • Average Prepaid Assets over 5 years is $3.0 million, with a median of $2.8 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2024: Prepaid Assets jumped 2286.63% in 2022, then tumbled 41.02% in 2024.
  • Over 5 years, Prepaid Assets stood at $2.8 million in 2022, then retreated by 27.22% to $2.1 million in 2023, then jumped by 103.51% to $4.2 million in 2024, then soared by 42.62% to $6.0 million in 2025, then tumbled by 35.49% to $3.8 million in 2026.
  • The last three Prepaid Assets figures came in at $3.8 million (Q2 2026), $6.0 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Jasper Therapeutics 20.11 Mn 20.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.84 Mn
Dec 31, 2025 5.95 Mn
Sep 30, 2025 3.67 Mn
Jun 30, 2025 3.46 Mn
Mar 31, 2025 4.38 Mn
Dec 31, 2024 4.17 Mn
Sep 30, 2024 2.30 Mn
Jun 30, 2024 1.86 Mn
Mar 31, 2024 1.83 Mn
Dec 31, 2023 2.05 Mn
Sep 30, 2023 1.35 Mn
Jun 30, 2023 2.76 Mn
Mar 31, 2023 3.11 Mn
Dec 31, 2022 2.82 Mn
Sep 30, 2022 1.46 Mn
Jun 30, 2022 2.47 Mn
Mar 31, 2022 3.40 Mn
Dec 31, 2021 3.13 Mn
Sep 30, 2021 1.50 Mn
Jun 30, 2021 103,577.00